Novo Nordisk’s Weight-Loss Pill Boom Faces Price War: Can Wegovy Stay on Top in 2026?

Novo Nordisk’s weight-loss pill wins FDA approval The global weight-loss drug market is entering a high-stakes phase—and at the center of it is Novo Nordisk and its blockbuster treatments Wegovy and Ozempic. But just as momentum builds, a fierce price war—sparked by rival Eli Lilly—is testing whether rapid prescription growth can truly translate into long-term … Read more